J. M. Gallego-Escuredo

发表

Reciprocal Effects of Antiretroviral Drugs Used To Treat HIV Infection on the Fibroblast Growth Factor 21/β-Klotho System

T. Quesada-López, F. Villarroya, J. Villarroya, 2018, Antimicrobial Agents and Chemotherapy.

Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients

F. Villarroya, G. Frühbeck, V. Catalán, 2014, International Journal of Obesity.

FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.

F. Villarroya, G. Frühbeck, V. Catalán, 2017, Clinical nutrition.

Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations

F. Villarroya, A. López-Bermejo, M. Díaz, 2015, International Journal of Obesity.

Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients

F. Villarroya, F. Vidal, M. Giralt, 2010, AIDS.

Uridine Metabolism in HIV-1-Infected Patients: Effect of Infection, of Antiretroviral Therapy and of HIV-1/ART-Associated Lipodystrophy Syndrome

F. Villarroya, A. Andreu, F. Vidal, 2010, PloS one.

Searching for Classical Brown Fat in Humans: Development of a Novel Human Fetal Brown Stem Cell Model

F. Villarroya, R. Squecco, D. Bani, 2016, Stem cells.

Hypertrophied Facial Fat in An HIV-1-Infected Patient after Autologous Transplantation from ‘Buffalo Hump’ Retains a Partial Brown-Fat-Like Molecular Signature

F. Villarroya, E. Martinez, J. Villarroya, 2013, Antiviral therapy.

Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines.

F. Villarroya, M. Giralt, P. Domingo, 2010, Current HIV research.

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue

F. Villarroya, J. Villarroya, M. Giralt, 2018, Aging cell.

Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.

F. Villarroya, P. Flachs, J. Kopecký, 2014, Metabolism: clinical and experimental.

Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV‐infected patients on combination antiretroviral therapy (cART). A sub‐study of a randomized, double‐blind, placebo‐controlled study

F. Villarroya, F. Vidal, J. Villarroya, 2018, Cytokine.

Reduced Levels of Serum FGF19 and Impaired Expression of Receptors for Endocrine FGFs in Adipose Tissue From HIV-Infected Patients

F. Villarroya, F. Vidal, M. Giralt, 2012, Journal of acquired immune deficiency syndromes.

The Molecular Signature of HIV-1-Associated Lipomatosis Reveals Differential Involvement of Brown and Beige/Brite Adipocyte Cell Lineages

F. Villarroya, E. Martinez, J. Villarroya, 2015, PloS one.

Differentially Altered Molecular Signature of Visceral Adipose Tissue in HIV-1–Associated Lipodystrophy

F. Villarroya, E. Targarona, J. Villarroya, 2013, Journal of acquired immune deficiency syndromes.

Adipogenic/Lipid, Inflammatory, and Mitochondrial Parameters in Subcutaneous Adipose Tissue of Untreated HIV-1–Infected Long-Term Nonprogressors: Significant Alterations Despite Low Viral Burden

F. Villarroya, C. Richart, F. Vidal, 2012, Journal of acquired immune deficiency syndromes.

Differential gene expression indicates that ‘buffalo hump’ is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy

F. Villarroya, E. Martinez, M. Giralt, 2008, AIDS.

Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.

F. Villarroya, M. Díaz, F. de Zegher, 2016, Diabetes & metabolism.

Genetic and Functional Mitochondrial Assessment of HIV-Infected Patients Developing HAART-Related Hyperlactatemia

F. Villarroya, Ò. Miró, E. Negredo, 2009, Journal of acquired immune deficiency syndromes.

Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications.

F. Villarroya, B. Clotet, E. Negredo, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High FGF21 levels are associated with altered bone homeostasis in HIV-1-infected patients.

F. Villarroya, F. Vidal, J. Villarroya, 2017, Metabolism: clinical and experimental.

Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines.

F. Villarroya, J. Villarroya, M. Giralt, 2016, Antiviral research.

Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration

R. Urtasun, F. Villarroya, J. Prieto, 2017, Gut.

Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study

F. Villarroya, J. Villarroya, M. Giralt, 2014, PloS one.

Current Management of Polycystic Ovary Syndrome: From Bench to Bedside

F. Villarroya, S. Vitale, A. López-Bermejo, 2018, International journal of endocrinology.

Histological and molecular features of lipomatous and nonlipomatous adipose tissue in familial partial lipodystrophy caused by LMNA mutations

F. Villarroya, B. González-Méndez, J. M. Gallego-Escuredo, 2012, Clinical endocrinology.

Postabdominoplasty Scar Improvement after a Single Session with an Automated 1210-nm Laser

S. Bohbot, J. M. Gallego-Escuredo, R. Palao, 2023, Plastic and reconstructive surgery. Global open.

Lipotoxicity on the basis of metabolic syndrome and lipodystrophy in HIV-1-infected patients under antiretroviral treatment.

F. Villarroya, J. Villarroya, M. Giralt, 2010, Current pharmaceutical design.

Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.

F. Villarroya, F. Vidal, J. Villarroya, 2015, The Journal of antimicrobial chemotherapy.

Brown adipose tissue in prepubertal children: associations with sex, birthweight, and metabolic profile

F. Villarroya, A. López-Bermejo, F. de Zegher, 2018, International Journal of Obesity.

Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokines.

F. Villarroya, M. Giralt, P. Domingo, 2011, Antiviral research.

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome

F. Villarroya, A. López-Bermejo, M. Díaz, 2018, International journal of endocrinology.

A 48-Week Study of Fat Molecular Alterations in HIV Naive Patients Starting Tenofovir/Emtricitabine With Lopinavir/Ritonavir or Efavirenz

F. Villarroya, F. Vidal, J. Villarroya, 2014, Journal of acquired immune deficiency syndromes.

Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study.

F. Villarroya, F. Vidal, J. Villarroya, 2017, Clinical nutrition.

Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy

F. Villarroya, F. Vidal, J. Villarroya, 2022, Journal of clinical medicine.